112
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Prognostic Factors for Penile Cancer and Survival in Response to Multimodality Therapy

, , , , & ORCID Icon
Pages 29-34 | Published online: 12 Feb 2020

References

  • Christodoulidou M, Sahdev V, Houssein S, Muneer A. Epidemiology of penile cancer. Curr Probl Cancer. 2015;39(3):126–136. doi:10.1016/j.currproblcancer.2015.03.01026076979
  • Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27(2):141–150. doi:10.1007/s00345-008-0302-z18607597
  • Pandey D, Mahajan V, Kannan RR. Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol. 2006;93(2):133–138. doi:10.1002/jso.2041416425300
  • Burt LM, Shrieve DC, Tward JD. Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys. 2014;88(1):94–100. doi:10.1016/j.ijrobp.2013.08.01324119832
  • Veeratterapillay R, Teo L, Asterling S, Greene D. Oncologic outcomes of penile cancer treatment at a UK supraregional center. Urology. 2015;85(5):1097–1103. doi:10.1016/j.urology.2014.11.04825769781
  • Korzeniowski MA, Crook JM. Contemporary role of radiotherapy in the management of penile cancer. Transl Androl Urol. 2017;6(5):855–867. doi:10.21037/tau.2017.07.0229184783
  • Martins FE, Rodrigues RN, Lopes TM. Organ-preserving surgery for penile carcinoma. Adv Urol. 2008;2008:1–7. doi:10.1155/2008/634216
  • National Comprehensive Cancer Network; 2019 Penile Cancer (Version 1.2019). Available from: https://www.nccn.org/professionals/physician_gls/pdf/penile.pdf. Accessed 419, 2019.
  • Pagliaro LC, Crook J. Multimodality therapy in penile cancer: when and which treatments? World J Urol. 2009;27(2):221–225. doi:10.1007/s00345-008-0310-z18682961
  • Mistry T, Jones RW, Dannatt E, Prasad KK, Stockdale AD. A 10-year retrospective audit of penile cancer management in the UK. BJU Int. 2007;100(6):1277–1281. doi:10.1111/j.1464-410X.2007.07168.x17850372
  • Chalya PL, Rambau PF, Masalu N, Simbila S. Ten-year surgical expereinces with penile cancer at a tertiary care hospital in northwestern Tanzania: a retrospective study of 236 patients. World J Sug Oncol. 2015;13:71. doi:10.1186/s12957-015-0482-0
  • Pond GR, Di Lorenzo G, Necchi A, et al. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy. Urol Oncol. 2014;32(4):501–508. doi:10.1016/j.urolonc.2013.10.00724332646
  • Hakenberg OW, Protzel C. Chemotherapy in penile cancer. Ther Adv Urol. 2012;4(3):133–138. doi:10.1177/175628721244123522654965
  • Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol. 2007;177(4):1335–1338. doi:10.1016/j.juro.2006.11.03817382727
  • Pagliaro LC, Williams DL, Daliani D, et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a Phase II study. J Clin Oncol. 2010;28(24):3851–3857. doi:10.1200/JCO.2010.29.547720625118
  • Pond GR, Milowsky MI, Kolinsky MP, et al. Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma. Clin Genitourin Cancer. 2014;12(6):440–446. doi:10.1016/j.clgc.2014.03.00924787971
  • Pettaway CA, Pagliaro L, Theodore C, Haas G. Treatment of visceral, unresectable, or bulky/unresectable regional metastases of penile cancer. Urology. 2010;76(2 Suppl 1):S58–S65. doi:10.1016/j.urology.2010.03.08220691886
  • Zhang K, Wan X, Xu H, et al. Surgical treatment of advanced penile cancer. J Cancer Res Clin Oncol. 2017;143(9):1865–1870. doi:10.1007/s00432-017-2435-128493019